Nasdaq: PCVXStockForm 13F30 Jun 2026

Hedge funds that hold Vaxcyte, Inc. Nasdaq: PCVX

CUSIP 92243G108 · who reports it, how much, and how much it matters to them

34 of the 720 hedge fund managers we track reported shares of Vaxcyte, Inc. (Nasdaq: PCVX) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Ra Capital Management, at USD 667m. The manager with the most riding on it is Kynam Capital Management, where it is 9.4% of the reported book.

Managers reporting it34of 720 we track
Value they reportUSD 1.6bnshares only, 30 Jun 2026
Funds they run406with a file on PPLI.com
Largest positionUSD 667mRa Capital Management
Typical weight0.1%median share of a manager's book
Heaviest weight9.4%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

34 managers, USD 1.6bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Vaxcyte, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 667m5.8%
2Deep Track Capital1 fund on PPLI.comUSD 250m3.6%
3Kynam Capital Management1 fund on PPLI.comUSD 170m9.4%
4D. E. Shaw & Co.15 funds on PPLI.comUSD 111m0.1%
5Maverick Capital20 funds on PPLI.comUSD 94m0.8%
6Polar Capital LLP26 funds on PPLI.comUSD 69m0.2%
7Adage Capital Management1 fund on PPLI.comUSD 51m0.1%
8Eversept Partners3 funds on PPLI.comUSD 37m1.9%
9Boothbay Fund Management2 funds on PPLI.comUSD 31m0.4%
10Boxer Capital Management1 fund on PPLI.comUSD 19m1.4%
11Two Sigma Investments35 funds on PPLI.comUSD 16m0.0%
12Artisan Partners1 fund on PPLI.comUSD 16m0.0%
13HighVista Strategies27 funds on PPLI.comUSD 8.7m2.0%
14Millennium Management6 funds on PPLI.comUSD 7.9m0.0%
15Edgestream Partners5 funds on PPLI.comUSD 7.6m0.2%
16Superstring Capital Management1 fund on PPLI.comUSD 3.9m2.5%
17Rock Springs Capital Management2 funds on PPLI.comUSD 3.5m0.2%
18Bridgewater Associates45 funds on PPLI.comUSD 2.9m0.0%
19Cormorant Asset Management1 fund on PPLI.comUSD 2.9m0.1%
20Hudson Bay Capital Management8 funds on PPLI.comUSD 2.6m0.0%
21Exoduspoint Capital Management7 funds on PPLI.comUSD 2.5m0.0%
22Engineers Gate Manager1 fund on PPLI.comUSD 1.9m0.0%
23Renaissance Technologies13 funds on PPLI.comUSD 1.1m0.0%
24Cinctive Capital Management5 funds on PPLI.comUSD 1m0.0%
25Brevan Howard Capital Management39 funds on PPLI.comUSD 984,0000.0%
26Persistent Asset Partners10 funds on PPLI.comUSD 878,0000.3%
27Aquatic Capital Management3 funds on PPLI.comUSD 808,0000.0%
28Landscape Capital Management4 funds on PPLI.comUSD 710,0000.0%
29Graham Capital Management18 funds on PPLI.comUSD 646,0000.0%
30The Quarry1 fund on PPLI.comUSD 584,0000.0%
31Capstone Investment Advisors25 funds on PPLI.comUSD 271,0000.0%
32CIBC Asset Management69 funds on PPLI.comUSD 263,0000.0%
33Bayforest Capital1 fund on PPLI.comUSD 215,0000.2%
34Walleye Capital8 funds on PPLI.comUSD 113,0000.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 9.4% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 170m9.4%
2Ra Capital ManagementUSD 667m5.8%
3Deep Track CapitalUSD 250m3.6%
4Superstring Capital ManagementUSD 3.9m2.5%
5HighVista StrategiesUSD 8.7m2.0%
6Eversept PartnersUSD 37m1.9%
7Boxer Capital ManagementUSD 19m1.4%
8Maverick CapitalUSD 94m0.8%
9Boothbay Fund ManagementUSD 31m0.4%
10Persistent Asset PartnersUSD 878,0000.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Vaxcyte, Inc.

What is the ticker symbol of Vaxcyte, Inc.?

Vaxcyte, Inc. trades under the symbol PCVX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 92243G108.

Which hedge funds own Vaxcyte, Inc. (Nasdaq: PCVX)?

34 of the 720 hedge fund managers PPLI.com tracks reported Vaxcyte, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 667m), Deep Track Capital (USD 250m), Kynam Capital Management (USD 170m), D. E. Shaw & Co. (USD 111m) and Maverick Capital (USD 94m).

How many hedge funds hold Vaxcyte, Inc.?

34 managers in our coverage reported it, and between them they run 406 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Vaxcyte, Inc.?

Kynam Capital Management, where the position was 9.4% of the reported 13F book at 30 June 2026.

Does this show who is short Vaxcyte, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Vaxcyte, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.